A new patent for our Sphere technology has issued today by The United States Patent and Trademark Office (USPTO).
Our disruptive Sphere technology is designed specifically for endovascular treatment of cerebral aneurysms occurring at bifurcations – a condition for which before the development of Sphere there was no acceptable endovascular treatment. The device is spherical in shape and consists of a high density patterned surface constructed from Nitinol® wire which when placed, reduces aneurysm inflow while being secured in the healthy parent vessel by two open loops. The decrease in flow into the aneurysm leads to thrombus formation in the sac of the aneurysm and ultimately healing and remodeling of the aneurysm and its neck
This patent which issued on March 4, 2014 as US 8,663,301 B2 covers:
- A single flexible wire loop stretched on a delivery system, allowing the implant to navigate through a tortuous path. The implant passively recoils when it is deployed at the site of the aneurysm.